Despite AI-linked threats and recent price target revisions, IQVIA Holdings Inc. (IQV) is considered one of the top life sciences stocks to buy by hedge funds. Truist Financial reiterated a Buy rating with a significant upside, while TD Cowen maintained a Hold rating, acknowledging AI’s long-term risks but uncertain immediate impact on Clinical Research Organizations. IQVIA provides extensive clinical research services, advanced analytics, and commercial solutions to the healthcare and life sciences sectors.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats
Despite AI-linked threats and recent price target revisions, IQVIA Holdings Inc. (IQV) is considered one of the top life sciences stocks to buy by hedge funds. Truist Financial reiterated a Buy rating with a significant upside, while TD Cowen maintained a Hold rating, acknowledging AI’s long-term risks but uncertain immediate impact on Clinical Research Organizations. IQVIA provides extensive clinical research services, advanced analytics, and commercial solutions to the healthcare and life sciences sectors.